Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Glenn J Hanna, M.D.

Concepts (240)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Oropharyngeal Neoplasms1620244925.810 Why?
Head and Neck Neoplasms32202529305.590 Why?
Carcinoma, Adenoid Cystic920242625.120 Why?
Papillomavirus Infections17202416393.560 Why?
Carcinoma, Squamous Cell22202440492.870 Why?
Salivary Gland Neoplasms520243062.530 Why?
Mouth Neoplasms1020245972.340 Why?
Papillomaviridae13202411392.240 Why?
DNA, Viral7202422012.160 Why?
Neoplasm Recurrence, Local21202594101.810 Why?
Neoadjuvant Therapy8202429020.930 Why?
Skin Neoplasms9202458590.860 Why?
Saliva220198530.850 Why?
Precancerous Conditions320249800.790 Why?
Leukoplakia, Oral42024790.780 Why?
Tumor Microenvironment6202439440.710 Why?
Immunotherapy11202447450.710 Why?
Sjogren's Syndrome120212400.650 Why?
Class I Phosphatidylinositol 3-Kinases420239040.640 Why?
Antineoplastic Agents82023136500.620 Why?
Proto-Oncogene Proteins c-bcl-6120191900.620 Why?
Tretinoin120215240.600 Why?
Chromosomes, Human, Pair 3120193220.590 Why?
Carcinoma, Merkel Cell420223290.550 Why?
Genomics6202059240.540 Why?
Quinolones120203890.540 Why?
Neoplasm Metastasis8202548920.510 Why?
Aged, 80 and over262024595480.510 Why?
Middle Aged4520252232330.500 Why?
Alphapapillomavirus320232190.500 Why?
Aged4020251713190.500 Why?
Antineoplastic Combined Chemotherapy Protocols72023118720.490 Why?
Humans9420257670400.480 Why?
Prognosis132024299630.460 Why?
Iodine Radioisotopes1201810290.450 Why?
Phosphatidylinositol 3-Kinases4202128830.440 Why?
Carcinoma, Neuroendocrine120183430.440 Why?
Genes, Tumor Suppressor1201810580.430 Why?
Kidney Transplantation3202442680.430 Why?
Proto-Oncogene Proteins p21(ras)2202317610.430 Why?
Immunotherapy, Adoptive1202315020.420 Why?
Immunophenotyping2201718640.420 Why?
Hematologic Neoplasms1202319070.380 Why?
Hypopharyngeal Neoplasms12011520.380 Why?
Adult3020252233170.380 Why?
Male4320253642030.370 Why?
Residence Characteristics1202121160.370 Why?
Neoplasms82023223500.360 Why?
Solitary Fibrous Tumors12011700.350 Why?
CD8-Positive T-Lymphocytes4202446480.350 Why?
Female4420253966600.350 Why?
Survival Analysis62020100920.340 Why?
Retrospective Studies242024816590.330 Why?
Hemangiosarcoma120112140.310 Why?
Breast Diseases120114410.290 Why?
Survivors1201823810.280 Why?
Thyroid Neoplasms2201823550.270 Why?
Drug Resistance, Neoplasm3201853320.260 Why?
Treatment Outcome122024652950.260 Why?
Hematoma120117660.260 Why?
Antibodies, Viral1201732120.240 Why?
DNA-Binding Proteins2201996120.240 Why?
Human papillomavirus 16220232680.230 Why?
Mutation102024302110.220 Why?
High-Throughput Nucleotide Sequencing4202036670.220 Why?
Brain Neoplasms1202491080.210 Why?
Adrenal Cortex Hormones2202418830.210 Why?
Protein-Arginine N-Methyltransferases120231290.210 Why?
Receptor, Notch1220245180.210 Why?
Neoplasm Staging62024112170.200 Why?
Vascular Endothelial Growth Factor A2202335110.200 Why?
Oncogene Proteins, Viral120233420.190 Why?
Transcription Factors32022121580.180 Why?
Genetic Predisposition to Disease22024180630.180 Why?
Vascular Endothelial Growth Factor Receptor-2120235470.180 Why?
Cohort Studies72024417180.180 Why?
Neoplasms, Second Primary2202310610.180 Why?
Hospitalization12020108150.180 Why?
Prospective Studies102024548860.170 Why?
Anus Neoplasms120243360.170 Why?
Hematopoietic Stem Cell Transplantation1201857160.170 Why?
Tumor Burden3202119030.160 Why?
Gene Expression Regulation, Neoplastic3202486280.160 Why?
Keratosis12019810.160 Why?
Patient Selection2202342560.160 Why?
Lip120201960.160 Why?
Breast Neoplasms22020211780.150 Why?
Proto-Oncogene Proteins c-myc120249980.150 Why?
Neoplasm Proteins3201835990.150 Why?
Gene Expression Profiling3202495320.150 Why?
Disease Progression42023136460.150 Why?
Combined Modality Therapy4202385350.140 Why?
Prostatic Neoplasms12020110970.140 Why?
Chloride Channels120182210.140 Why?
Tumor Virus Infections120204370.140 Why?
Osteoradionecrosis12017510.140 Why?
Microsatellite Repeats120187840.130 Why?
Frameshift Mutation120183920.130 Why?
Hyperbaric Oxygenation120171660.130 Why?
Radiotherapy, Intensity-Modulated120227980.130 Why?
Young Adult72023599800.120 Why?
DNA3202472100.120 Why?
Polymerase Chain Reaction1202460670.120 Why?
Salvage Therapy1202112710.120 Why?
Oncogenes1202012320.120 Why?
Otorhinolaryngologic Surgical Procedures120183250.120 Why?
Clinical Trials as Topic2202380480.120 Why?
United States62025729710.120 Why?
Oncogene Proteins120187150.110 Why?
Societies, Medical2202339640.110 Why?
Gene Dosage1201812110.110 Why?
Disease-Free Survival2202168440.110 Why?
TOR Serine-Threonine Kinases3202320610.110 Why?
Geriatric Assessment1202014220.100 Why?
Urban Population1202020440.100 Why?
Drug Synergism1201617590.100 Why?
Interferon-gamma1202031540.100 Why?
Myringoplasty12011120.100 Why?
Radiosurgery1202113300.090 Why?
Nuclear Proteins3202357940.090 Why?
Androgen Antagonists1202014120.090 Why?
Carcinoma1202223260.090 Why?
Survival Rate32023128230.090 Why?
Molecular Targeted Therapy2202028240.090 Why?
Middle Ear Ventilation120111010.090 Why?
DNA Copy Number Variations1201920470.090 Why?
Lymphatic Metastasis2201529000.090 Why?
Rural Population1202023210.080 Why?
Radiotherapy Dosage3202229150.080 Why?
DNA Mutational Analysis1201841140.080 Why?
Receptor, erbB-21202025990.080 Why?
Medical Oncology1202023410.080 Why?
Feasibility Studies1201953110.070 Why?
Sirolimus1201415390.070 Why?
Sarcoma1201818020.070 Why?
Predictive Value of Tests12023154240.070 Why?
Graft Rejection1202044980.070 Why?
Genome, Human1202044410.070 Why?
Neoplasms, Radiation-Induced120115420.070 Why?
Incidence32020215260.070 Why?
Biopsy1201867770.060 Why?
Pilot Projects1201987320.060 Why?
Comorbidity12020105820.060 Why?
T-Lymphocytes12023102540.060 Why?
SEER Program2202014440.060 Why?
Tumor Suppressor Proteins1201428000.060 Why?
Logistic Models12019132840.060 Why?
Ifosfamide120232330.050 Why?
Carcinoma, Ductal, Breast1201110970.050 Why?
Lipid A12022700.050 Why?
Radiotherapy Planning, Computer-Assisted2202216770.050 Why?
Oncogene Proteins, Fusion2202216080.050 Why?
Cross-Sectional Studies12022263250.050 Why?
Parotid Gland120221780.050 Why?
Organs at Risk120223670.040 Why?
Histone Demethylases120223280.040 Why?
Cell Cycle Proteins2202234400.040 Why?
Kaplan-Meier Estimate2202065130.040 Why?
Toll-Like Receptor 4120225880.040 Why?
Education, Medical, Graduate1201124200.040 Why?
Methylprednisolone120203860.040 Why?
Quality of Life12020134850.040 Why?
Cell Transformation, Viral120205270.040 Why?
Hypokalemia120191520.040 Why?
Signal Transduction22018236210.040 Why?
Mucositis120191080.040 Why?
Clinical Trials, Phase II as Topic120206380.040 Why?
Virus Integration120203070.040 Why?
Jaw12017950.030 Why?
Time-Lapse Imaging120171940.030 Why?
Maximum Tolerated Dose120198960.030 Why?
raf Kinases120161170.030 Why?
Genome, Viral120206730.030 Why?
Workflow120218590.030 Why?
Spheroids, Cellular120173280.030 Why?
Prednisone1202015660.030 Why?
Sex Distribution1202022760.030 Why?
Diagnosis, Differential12011129860.030 Why?
Clinical Competence1201148590.030 Why?
Radiotherapy, Adjuvant1202017880.030 Why?
MAP Kinase Kinase Kinases120162520.030 Why?
Follow-Up Studies12017393170.030 Why?
Cytokines2202274460.030 Why?
Sensitivity and Specificity22020146720.030 Why?
Age Distribution1202028700.030 Why?
Receptor, Notch212015900.030 Why?
ras GTPase-Activating Proteins12015950.030 Why?
Lymphocytes, Tumor-Infiltrating1202011050.030 Why?
Cisplatin1202016560.030 Why?
Adolescent22023890460.030 Why?
Postoperative Period1201918240.030 Why?
Quality-Adjusted Life Years1202017410.030 Why?
Age of Onset1202033440.030 Why?
Radiation Dosage1202219650.030 Why?
Gene Rearrangement1201811410.030 Why?
Genetic Heterogeneity120167350.030 Why?
Immunity1201810020.030 Why?
Diarrhea1201913190.020 Why?
In Situ Hybridization, Fluorescence1201825090.020 Why?
Phylogeny1202028400.020 Why?
Immunologic Factors1202115920.020 Why?
Analysis of Variance1202062150.020 Why?
Income1202018770.020 Why?
Chemotherapy, Adjuvant1202035520.020 Why?
Cyclin-Dependent Kinase Inhibitor p16120157050.020 Why?
Microfluidic Analytical Techniques120177890.020 Why?
Lymph Nodes1202334680.020 Why?
Drug Administration Schedule1201948550.020 Why?
Cell Line, Tumor22017170970.020 Why?
Cell Culture Techniques1201716460.020 Why?
Tumor Cells, Cultured1201761060.020 Why?
Killer Cells, Natural1201822090.020 Why?
Models, Educational120113750.020 Why?
Tomography, X-Ray Computed22023207410.020 Why?
Recurrence1202085040.020 Why?
Computational Biology1202035670.020 Why?
Flow Cytometry1201758910.020 Why?
Protein Conformation1201439480.020 Why?
Proto-Oncogene Proteins B-raf1201620580.020 Why?
Statistics, Nonparametric1201128500.020 Why?
Antibodies, Monoclonal1202292450.020 Why?
Genotype12020130350.020 Why?
Reproducibility of Results12023201690.010 Why?
Longitudinal Studies12020147660.010 Why?
Tumor Suppressor Protein p531201529520.010 Why?
Case-Control Studies12022222540.010 Why?
Educational Measurement1201112590.010 Why?
Immunohistochemistry12017110630.010 Why?
Base Sequence12015124140.010 Why?
Smoking1202090810.010 Why?
Sequence Analysis, DNA1201547800.010 Why?
Radiography1201469750.010 Why?
Practice Guidelines as Topic1202074350.010 Why?
Magnetic Resonance Imaging22021365820.010 Why?
Polymorphism, Single Nucleotide12020160360.010 Why?
Lung Neoplasms12023134910.010 Why?
Child12023807710.010 Why?
Internship and Residency1201159470.010 Why?
Mice12017819120.010 Why?
Animals120171689650.000 Why?
Hanna's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (240)
Explore
_
Co-Authors (163)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.